A prolonged QT interval creates an electro-physiological environment that is favorable for the development of cardiac arrhythmias. A new study in Holland suggests that yet another group of ...

Please provide your email address to receive an email when new articles are posted on . For more than a decade, numerous studies have reported that macrolide and fluoroquinolone antibiotics have been ...

CredibleMeds, a valuable resource for prescribing physicians, now includes information from FDA drug labels to inform prescribers of any ECG monitoring recommendations, warnings for use in congenital ...

Boston, MA - Patients who receive high doses of the antidepressants citalopram or escitalopram could potentially develop QT-interval prolongation, a marker of a slight increased risk for ventricular ...

Uncertainty remains regarding the value of heart-rate-corrected QT interval (QTc) prolongation on electrocardiogram for predicting cardiovascular disease (CVD), particularly among Asian populations.

Arsenic trioxide (ATO) is a highly effective agent for the treatment of acute promyelocytic leukemia (APL). QT interval prolongation is common with ATO and can pose a barrier to effective ...

For many years, moderate alcohol intake and its effect on health have been subject to much debate, particularly concerning cardiovascular health. Indeed, light-to-moderate use of alcohol has been ...

Silver Spring, MD - The FDA's Cardiovascular and Renal Drugs Advisory Committee has ruled that the clinical trials conducted by Bayer/GlaxoSmithKline for its erectile dysfunction drug, vardenafil ...

MALVERN, Pa., March 25, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), a leading remote medical technology company focused on the delivery of health information to improve quality of life ...

QT Prolongation Risk Assessed for Non-SSRI Antidepressants Although the FDA requires drug companies to do extensive side-effect testing on their products prior to approval, including QT and QTc ...

Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research ...

SAN DIEGO, INDIANAPOLIS, and WALTHAM, Mass., July 7, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today ...